The page lists 53 projects related to the topic "immuno".
# | |||
---|---|---|---|
1 | SAPHIR | Strengthening Animal Production and Health through the Immune Response | 2015 |
2 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
3 | POSEIDON | Plasmonic-based autOmated lab-on-chip SEnsor for the rapid In-situ Detection of LegiONella | 2015 |
4 | Immuno-NanoDecoder | Nanostructured molecular decoders for the quantitative, multiplexed, layer-by-layer detection of disease-associated proteins | 2015 |
5 | WntTraffic | Characterising the spatial organisation and regulation of the Wnt receptor complex in stem cells and cancer | 2016 |
6 | HUMICE | AXENIS Humanized Mice – Innovation towards industrial scale-up | 2015 |
7 | LAUREN | bLadder cAncer URine cEll aNalysis | 2015 |
8 | Drug-Seq | Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing | 2015 |
9 | PANDORA | Probing safety of nano-objects by defining immune responses of environmental organisms | 2016 |
10 | AcTafactors | AcTafactors: Tumor Necrosis Factor-based immuno-cytokines with superior therapeutic indexes | 2015 |
11 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
12 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
13 | STREAM | Strategies towards Excellence in Immuno-Oncology | 2016 |
14 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
15 | EN_ACTI2NG | European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry | 2017 |
16 | TRAIN | Tribbles Research and Innovation Network | 2016 |
17 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
18 | MultiViVax | Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria | 2017 |
19 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
20 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
21 | 3DPD | PhD position in commercial environment: cancer immunotherapy drug screening in 3D | 2017 |
22 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
23 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
24 | FILODIAG | Ultra-Fast Molecular Filovirus Diagnostics - Sofia ref.: 115844 | 2015 |
25 | LD_Biogenesis | Identification and characterization of sites of lipid droplet biogenesis in the ER | 2018 |
26 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
27 | MEL-Interactions | An integrative approach for the exploration of melanoma genetic and immunological interactions | 2018 |
28 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
29 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
30 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
31 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
32 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
33 | SensApp | Super-sensitive detection of Alzheimer’s disease biomarkers in plasma by an innovative droplet split-and-stack approach | 2019 |
34 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
35 | MP-101 | a novel drug for prevention and treatment peripheral neuropathy symptoms | 2019 |
36 | COLIBRI | Click chemistry Options for Live Immuno Brain Imaging | 2019 |
37 | Lac-TB | Dissecting the impact of Lactate in Tuberculosis | 2020 |
38 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
39 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
40 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
41 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
42 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
43 | FreeATPOC | Towards an instrument-free future of molecular diagnostics at the point-of-care | 2020 |
44 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
45 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
46 | AVANT | Alternatives to Veterinary ANTimicrobials | 2020 |
47 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
48 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
49 | MemDense | Cellular control of membrane protein density in the endoplasmic reticulum via the unfolded protein response | 2020 |
50 | TAVI4Life | A lifelong transcatheter aortic valve prosthesis | 2020 |
51 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
52 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
53 | PLIM-G4 | Long-lived optical probes to image G-quadruplex DNA in live cells | 2021 |